AstraZeneca cancer drug, companion test approved
Friday, December 19, 2014 - 13:30
in Health & Medicine
WASHINGTON, D.C. (AP) -- U.S. regulators have granted accelerated approval to the first in a new class of drugs for ovarian cancer, AstraZeneca PLC's Lynparza....